Dry eye disease (DED), keratoconjunctivitis sicca or dysfunctional tear syndrome, is the most
prevalent ophthalmic disease which affects a substantial segment of people worldwide with …

Dry eye disease (DED) is a frequently observed eye complaint, which has recently attracted
considerable research interest. Conventional therapy for DED involves the use of artificial …

Dry eye disease (DED) is one of the most common ocular surface disorders characterised by
a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature …

This research assesses the beneficial effects of loading terconazole, a poorly water-soluble
antifungal drug in silica/chitosan nanoparticles (SCNs) for ocular delivery. Nanoparticles …

Eye drops are the most common and convenient route of topical administration and the first
choice of treatment for many ocular diseases. However, the ocular bioavailability of …

Uveitis is a vision inflammatory disorder with a high prevalence in developing countries.
Currently, marketed treatments remain limited and reformulation is usually performed to …

Rapalogs, including sirolimus and everolimus, as well as tacrolimus, are macrolide
immunosuppressants that have emerged as promising therapeutic agents in ophthalmology …

Immune ophthalmopathy is a collection of autoimmune eye diseases. Immunosuppressants
are drugs that can inhibit the body's immune response. Considering drug side effects such …

Effective drug distribution at the intended or particular location is a critical issue that
researchers are now dealing. Nanosponges have significantly increased in importance in …

Purpose: Difluprednate (DFP) is an approved corticosteroid, available as an ophthalmic
emulsion (Durezol®), used to treat pain and inflammation of the eye following ocular …